| 
| Entry date | September 24, 2002  12:00 +1GMT 
 |  | Last update | July 14, 2019  22:28 +1GMT 
 |  | Allergome Code | 555 
 |  | Name | Phl p 2   
 |  | Common Names | a3419, g206, Grasses, Group 2, Group 2, Grasses 
 |  | Biological Function | Unknown 
 |  | Isoforms, Variants, Epitopes
 | Phl p 2.0101 
 |  | Hybrids, Polymers & Shuffleds
 | Phl p P1-P2-P5-P6, Phl p P2-P6, Phl p P6-P2 
 |  | Links to Molecule Sequences
 | Phl p 2.0101 - P43214 - UNIPROT 
 |  | Links to Molecule Structure
 | Phl p 2 - 1BMW - PDB, Phl p 2 - 1WHO - PDB, Phl p 2 - 1WHP - PDB, Phl p 2 - 2VXQ - PDB 
 |  | Sources |  |  | Links to Source Taxonomy
 | Phl p - 15957 - NCBI, Phl p - 15957 - UniProt, Phl p - 41062 - ITIS, Phl p - Discover Life, Phl p - Wikipedia 
 |  | Links to Source Images | Phleum pratense on Google images |  | Tissues | Pollen 
 |  | Routes of Exposure | Inhalation 
 |  | Epidemiology from Literature
 | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography |  | 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 25 | 68.000 |  |  | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 29.600 | 20120310, Twaroch TE |  | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Austria | IgE | 29 | 69.000 |  |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 1994 | Austria | IgE | 30 | 60.000 |  |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 53.000 | 20131014, Bokanovic D |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 53.000 | 20131014, Bokanovic D |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 49.000 | 20131014, Bokanovic D |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | IgE | 82 | 82.900 | 20080314, Westritschnig K |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 1993 | Austria | IgE (IB) | 98 | 62.000 |  |  | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | SPT | 82 | 59.750 | 20080314, Westritschnig K |  | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 15.110 | 20101214, Gadisseur R |  | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ |  | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG |  | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 13.640 | 20091121, Ebo DG |  | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 70.000 | 20091121, Ebo DG |  | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 48.640 | 20090826, Ebo DG |  | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 34.340 | 20110223, De Knop KJ |  | 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 34 | 55.900 | 20141118, Santiago HD |  | 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 30 | 33.300 | 20141118, Santiago HD |  | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Canada | IgE | 15 | 20.000 |  |  | ... complete "Epidemiology from Literature" listing -> | 
 |  | References | Biochemistry / Structure / Function 2014:
 20141122, Focke-Tejkl M
	 - 20141118, Santiago HD
	 - 20140815, Devanaboyina SC
	 - 20140331, Lollier V
 2013:
 20130731, DallAntonia F
	 - 20130212, Schulten V
 2012:
 20121203, Gadermaier E
	 - 20121127, Vaughan K
	 - 20120720, Santiago HC
 2011:
 20111222, Abou Chakra OR
	 - 20111107, Pfiffner P
	 - 20110829, DallAntonia F
 2010:
 20101012, Schmidt H
	 - 20100528, Breen JM
	 - 20100208, Rouvinen J
 2009:
 20090702, Johansen N
	 - 20090207, Padavattan S
 2008:
 20081030, Kerff F
	 - 20081027, Ivanciuc O
	 - 20080919, Mothes-Luksch N
 ... complete Reference listing ->
 
 Molecular Biology
 2014:
 20141122, Focke-Tejkl M
 2013:
 20130212, Schulten V
 2009:
 20090811, Roesler E
	 - 20090207, Padavattan S
 2008:
 20080919, Mothes-Luksch N
	 - 20080716, Linhart B
 2006:
 20060602, Petersen A
 2005:
 20050504, Linhart B
 2002:
 2002, Linhart B
 1999:
 1999, Pandjaitan B
 1996:
 1996b, Vrtala S
 1993:
 1993, Dolecek C
 
 Immunochemistry / Allergenicity
 2014:
 20141122, Focke-Tejkl M
	 - 20140815, Devanaboyina SC
	 - 20140210, Aberer W
 2013:
 20131120, Gadermaier E
	 - 20130820, Baron-Bodo V
	 - 20130613, Levin M
	 - 20130212, Schulten V
 2012:
 20121203, Gadermaier E
	 - 20120515, James LK
 2011:
 20111222, Abou Chakra OR
	 - 20110829, DallAntonia F
 2010:
 20101211, Madritsch C
	 - 20101012, Schmidt H
	 - 20100426, Vigh-Conrad KA
 2009:
 20090407, Sander I
	 - 20090207, Padavattan S
 2008:
 20080919, Mothes-Luksch N
	 - 20080716, Linhart B
	 - 20080618, Focke M
	 - 20080314, Westritschnig K
 ... complete Reference listing ->
 
 Immune-mechanisms / Genetics
 2014:
 20141122, Focke-Tejkl M
	 - 20140721, Schulten V
 2013:
 20130212, Schulten V
 2012:
 20120510, Eckl-Dorna J
 2010:
 20100617, Oseroff C
 2006:
 20061019, Niederberger V
 2005:
 20050504, Linhart B
 2002:
 2002a, Niederberger V
	 - 2002, Hauswirth AW
	 - 2002, Flicker S
 2000:
 2000, Van Neerven RJ
 1995:
 1995, Maurer D
	 - 1995, Dolecek C
 
 Detection - Source Extracts, Food Products, Drug Preparations
 2004:
 20040312, Marth K
 1993:
 1993a, Vrtala S
 
 Detection - Allergy Diagnostic and Immunotherapeutic Products
 2010:
 20101012, Schmidt H
 2008:
 20080618, Focke M
 2007:
 20070523, Metz-Favre C
 
 Detection - Source Tissues
 1993:
 1993, Dolecek C
 
 Epidemiology
 2014:
 20141118, Santiago HD
	 - 20140625, Armentia A
	 - 20140606, Panzner P
 2013:
 20131017, Prosperi MC
	 - 20131014, Bokanovic D
 2012:
 20121220, Pomponi D
	 - 20120730, Hatzler L
	 - 20120528, Patelis A
	 - 20120220, Nordlund B
 2011:
 20111215, Alessandri C
	 - 20111214, Zheng YW
	 - 20111122, Melioli G
	 - 20110810, Dottorini T
 2010:
 20100301, Scala E
 2009:
 20090826, Ebo DG
 2008:
 20080319, Rossi RE
 2006:
 20061007, Moverare R
 2004:
 20041224, Moverare R
 2003:
 2003a, Westritschnig K
	 - 2003, Mari A
 ... complete Reference listing ->
 
 Diagnosis
 2014:
 20141122, Hochwallner H
	 - 20141003, Beitia JM
	 - 20140909, Rea F
	 - 20140909, Bozek A
	 - 20140827, Hannula-Jouppi K
	 - 20140815, Alvarado MI
	 - 20140721, Has C
	 - 20140609, Rentzos G
	 - 20140604, Marth K
	 - 20140505, Pillai P
	 - 20140331, Rockmann H
	 - 20140328, Palgan K
	 - 20140324, Heaps A
	 - 20140306, Darsow U
	 - 20140211, Martinez-Aranguren R
	 - 20140210, Aberer W
	 - 20140127, Konradsen JR
	 - 20140118, Conti A
 2013:
 20131209, Cabauatan CR
	 - 20131124, De Linares C
 ... complete Reference listing ->
 
 Immunotherapy
 2012:
 20120206, Klimek L
 2005:
 20050915, Jutel M
 
 Experimental Model - Allergic Immune Response
 2014:
 20141122, Focke-Tejkl M
	 - 20141118, Santiago HD
 2009:
 20090811, Roesler E
 2008:
 20080919, Mothes-Luksch N
	 - 20080716, Linhart B
 2007:
 20070414, Kildsgaard J
	 - 20070306, Linhart B
 2005:
 20050504, Linhart B
 2001:
 2001, Hochreiter R
 
 Experimental Model - Inhalant-induced Diseases
 2002:
 2002, Linhart B
 1998:
 1998, Vrtala S
 
 Review, Editorial, Report Citations, Other Resources
 2015:
 20151220, Vieira FM
 2014:
 20141126, Cingi C
	 - 20141029, Frazier A
	 - 20141011, Jutel M
	 - 20141001, Jongejan L
	 - 20140926, Akdis M
	 - 20140919, Popescu FD
	 - 20140731, Baird FJ
	 - 20140704, Nelson HS
	 - 20140623, Ferreira F
	 - 20140530, Bonini M
	 - 20140417, Ladics GS
	 - 20140401, Davies JM
	 - 20140317, Thomas WR
	 - 20140304, Matricardi PM
 2013:
 20131203, Gadermaier E
	 - 20131128, Wallner M
	 - 20131024, Jutel M
	 - 20131020, Renz H
	 - 20131004, Canonica GW
 ... complete Reference listing ->
 |  |